Was the drop in mammography rates in 2005 associated with the drop in hormone therapy use?

Cancer

Volumn 117, Issue 24, 2011, Pages 5450-5460

  Breen, Nancy ^a   Cronin, Kathleen A ^b   Tiro, Jasmin A ^c   Meissner, Helen I ^d   McNeel, Timothy S ^e   Sabatino, Susan A ^f   Tangka, Florence K ^f   Taplin, Stephen H ^b  

^a National Institutes   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e INFORMATION MANAGEMENT SERVICES INC   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

breast cancer; hormone therapy; mammography; National Health Interview Surveys; primary care; women's health

Indexed keywords

HORMONE;

ADULT; AGE; AGED; ARTICLE; ASIAN; BREAST CANCER; CANCER SCREENING; CAUCASIAN; CONTROLLED STUDY; DRUG WITHDRAWAL; EDUCATIONAL STATUS; FEMALE; GYNECOLOGY; HEALTH CARE FACILITY; HEALTH INSURANCE; HEALTH STATUS; HISPANIC; HORMONAL THERAPY; HUMAN; IMMIGRANT; INTERPERSONAL COMMUNICATION; INTERVIEW; MAMMOGRAPHY; MEDICARE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEGRO; PHYSICIAN; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

BREAST NEOPLASMS; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; UNITED STATES;

EID: 84860390044     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.26218     Document Type: Article

References (38)

1. Breen N, Cronin KA, Meissner HI, et al. Reported drop in mammography: is this cause for concern? Cancer. 2007; 109: 2405-2409. (Pubitemid 46906458)
2. Ryerson AB, Miller J, Eheman CR, White MC,. Use of mammograms among women aged ≥40 years-United States, 2000-2005. MMWR Morb Mortal Wkly Rep. 2007; 56: 49-51.
3. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002; 288: 321-333. (Pubitemid 34761611)
4. Buist DS, Newton KM, Miglioretti DL, et al. Hormone therapy prescribing patterns in the United States. Obstet Gynecol. 2004; 104: 1042-1050. (Pubitemid 40458772)
5. Hersh AL, Stefanick ML, Stafford RS,. National use of postmenopausal hormone therapy: annual trends and response to recent evidence. JAMA. 2004; 291: 47-53. (Pubitemid 38040534)
6. Borrayo EA, Hines L, Byers T, et al. Characteristics associated with mammography screening among both Hispanic and non-Hispanic white women. J Womens Health (Larchmt). 2009; 18: 1585-1594.
7. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R,. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst. 2001; 93: 1704-1713. (Pubitemid 33130259)
8. Taplin SH, Ichikawa L, Buist DS, Seger D, White E,. Evaluating organized breast cancer screening implementation: the prevention of late-stage disease? Cancer Epidemiol Biomarkers Prev. 2004; 13: 225-234. (Pubitemid 38222553)
9. Starfield B, Shi L, Macinko J,. Contribution of primary care to health systems and health. Milbank Q. 2005; 83: 457-502. (Pubitemid 41551756)
10. Meissner HI, Breen N, Taubman ML, Vernon SW, Graubard BI,. Which women aren't getting mammograms and why? (United States). Cancer Causes Control. 2007; 18: 61-70. (Pubitemid 46020902)
11. Klabunde CN, Riley GF, Mandelson MT, Frame PS, Brown ML,. Health plan policies and programs for colorectal cancer screening: a national profile. Am J Manag Care. 2004; 10: 273-279. (Pubitemid 38480797)
12. Baker LC, Brown ML,. Managed care, consolidation among health care providers, and health care: evidence from mammography. Rand J Econ. 1999; 30: 351-374.
13. Baker LC, Phillips KA, Haas JS, Liang SY, Sonneborn D,. The effect of area HMO market share on cancer screening. Health Serv Res. 2004; 39: 1751-1772. (Pubitemid 39601250)
14. Glass AG, Lacey JV Jr, Carreon JD, Hoover RN,. Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status. J Natl Cancer Inst. 2007; 99: 1152-1161. (Pubitemid 47233065)
15. National Center for Health Statistics. 2005 National Health Interview Survey (NHIS) public use data release: NHIS survey description, June 2006. National Center for Health Statistics Web site. Available at:. Accessed January 3, 2011.
16. National Center for Health Statistics. 2000 National Health Interview Survey (NHIS) public use data release: NHIS survey description, 2002. National Center for Health Statistics Web site. Available at:. Accessed January 3, 2011.
17. Office of Management and Budget (OMB). Statistical programs and standards, 2008. OMB Web site. Available at:. Accessed January 3, 2011.
18. Makuc DM, Breen N, Meissner HI, Vernon SW, Cohen A,. Financial barriers to mammography: who pays out-of-pocket? J Womens Health (Larchmt). 2007; 16: 349-360. (Pubitemid 46668916)
19. Breen N, Gentleman JF, Schiller JS,. Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer. 2011; 117: 2209-2218.
20. Cunningham PJ, Felland LE,. Falling behind: Americans' access to medical care deteriorates, 2003-2007. Track Rep. 2008; 19: 1-5.
21. Hiatt RA, Klabunde C, Breen N, Swan J, Ballard-Barbash R,. Cancer screening practices from National Health Interview Surveys: past, present, and future. J Natl Cancer Inst. 2002; 94: 1837-1846. (Pubitemid 36104628)
22. Graubard BI, Korn EL,. Predictive margins with survey data. Biometrics. 1999; 55: 652-659. (Pubitemid 29302598)
23. Ravdin PM, Cronin KA, Howlader N, et al. The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med. 2007; 356: 1670-1674. (Pubitemid 46631679)
24. Caan B, Habel L, Quesenberry C, Kushi L, Herrinton L,. Re: declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008; 100: 597-598.
25. Robbins AS, Clarke CA,. Regional changes in hormone therapy use and breast cancer incidence in California from 2001 to 2004. J Clin Oncol. 2007; 25: 3437-3439. (Pubitemid 47310880)
26. Farhat GN, Walker R, Buist DS, Onega T, Kerlikowske K,. Changes in invasive breast cancer and ductal carcinoma in situ rates in relation to the decline in hormone therapy use. J Clin Oncol. 2010; 28: 5140-5146.
27. Hiatt RA, Breen N,. The social determinants of cancer: a challenge for transdisciplinary science. Am J Prev Med. 2008; 35: S141-S150. (Pubitemid 351932071)
28. Cronin KA, Miglioretti DL, Krapcho M, et al. Bias associated with self-report of prior screening mammography. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1699-1705.
29. Rauscher GH, Johnson TP, Cho YI, Walk JA,. Accuracy of self-reported cancer-screening histories: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2008; 17: 748-757. (Pubitemid 351536402)
30. Newell SA, Girgis A, Sanson-Fisher RW, Savolainen NJ,. The accuracy of self-reported health behaviors and risk factors relating to cancer and cardiovascular disease in the general population: a critical review. Am J Prev Med. 1999; 17: 211-229. (Pubitemid 29424201)
31. Eggen D, Stein R,. Mammograms and politics: task force stirs up a tempest. The Washington Post. November 18, 2009: A1.
32. Berry DA,. Benefits and risks of screening mammography for women in their forties: a statistical appraisal. J Natl Cancer Inst. 1998; 90: 1431-1439. (Pubitemid 28482007)
33. Nystrom L, Andersson I, Bjurstam N, Frisell J, Nordenskjold B, Rutqvist LE,. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet. 2002; 359: 909-919. (Pubitemid 34246378)
34. Gotzsche PC, Olsen O,. Is screening for breast cancer with mammography justifiable? Lancet. 2000; 355: 129-134. (Pubitemid 30068564)
35. Elmore JG, Nakano CY, Koepsell TD, Desnick LM, D'Orsi CJ, Ransohoff DF,. International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst. 2003; 95: 1384-1393. (Pubitemid 37220458)
36. Makuc DM, Freid VM, Parsons PE,. Health insurance and cancer screening among women. Adv Data. 1994; 254: 1-12.
37. Baron RC, Melillo S, Rimer BK, et al. Intervention to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers a systematic review of provider reminders. Am J Prev Med. 2010; 38: 110-117.
38. Sabatino SA, Habarta N, Baron RC, et al. Interventions to increase recommendation and delivery of screening for breast, cervical, and colorectal cancers by healthcare providers systematic reviews of provider assessment and feedback and provider incentives. Am J Prev Med. 2008; 35: S67-S74. (Pubitemid 351787506)